Vicarious Surgical Files 8-K with Stock and Warrant Details
Ticker: RBOTW · Form: 8-K · Filed: Sep 25, 2025 · CIK: 1812173
| Field | Detail |
|---|---|
| Company | Vicarious Surgical Inc. (RBOTW) |
| Form Type | 8-K |
| Filed Date | Sep 25, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $11.50 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, stock-information, warrants
TL;DR
Vicarious Surgical filed an 8-K on 9/25/25 detailing stock and warrants.
AI Summary
Vicarious Surgical Inc. filed an 8-K on September 25, 2025, reporting other events and financial statements/exhibits. The company, formerly known as D8 Holdings Corp. until May 14, 2020, is incorporated in Delaware and headquartered in Waltham, MA. The filing includes details about its common stock and warrants to purchase shares at an exercise price of $11.50.
Why It Matters
This filing provides an update on Vicarious Surgical's corporate structure and financial instruments, which could be relevant for investors tracking the company's equity and potential dilution.
Risk Assessment
Risk Level: low — This is a routine filing providing corporate and financial information without immediate material news.
Key Numbers
- 11.50 — Warrant Exercise Price (Price at which warrants can be exercised to purchase shares.)
Key Players & Entities
- Vicarious Surgical Inc. (company) — Registrant
- D8 Holdings Corp. (company) — Former company name
- September 25, 2025 (date) — Date of earliest event reported
- May 14, 2020 (date) — Date of name change
- 11.50 (dollar_amount) — Warrant exercise price
FAQ
What specific 'Other Events' are detailed in this 8-K filing?
The provided text does not specify the 'Other Events' beyond indicating that this item is included in the filing.
What are the details of the warrants mentioned in the filing?
The filing mentions warrants to purchase one share of Class Common Stock each at an exercise price of $11.50 per share.
When did Vicarious Surgical Inc. change its name from D8 Holdings Corp.?
The company changed its name from D8 Holdings Corp. on May 14, 2020.
What is the par value of Vicarious Surgical Inc.'s Class Common Stock?
The par value of Vicarious Surgical Inc.'s Class Common Stock is $0.0001 per share.
What is the SIC code for Vicarious Surgical Inc.?
The Standard Industrial Classification (SIC) code for Vicarious Surgical Inc. is 3842, which pertains to Orthopedic, Prosthetic & Surgical Appliances & Supplies.
Filing Stats: 584 words · 2 min read · ~2 pages · Grade level 10.6 · Accepted 2025-09-25 16:15:25
Key Financial Figures
- $0.0001 — tered Class A common stock, par value $0.0001 per share RBOT The New York Stock E
- $11.50 — mon stock, each at an exercise price of $11.50 per share RBOT WS The New York Stoc
Filing Documents
- ea0258779-8k_vicarious.htm (8-K) — 31KB
- ea025877901ex99-1_vicarious.htm (EX-99.1) — 12KB
- 0001213900-25-091651.txt ( ) — 254KB
- rbot-20250925.xsd (EX-101.SCH) — 4KB
- rbot-20250925_def.xml (EX-101.DEF) — 26KB
- rbot-20250925_lab.xml (EX-101.LAB) — 36KB
- rbot-20250925_pre.xml (EX-101.PRE) — 25KB
- ea0258779-8k_vicarious_htm.xml (XML) — 6KB
01. Other
Item 8.01. Other Events. On September 25, 2025, Vicarious Surgical Inc. (the "Company") announced that its board of directors (the "Board") has appointed Joseph Doherty to serve as Chairman of the Board. Mr. Doherty joined the Board following his election at the Company's annual meeting of stockholders held on June 27, 2025, and he currently serves as a member of the Board's Compensation Committee and as the Chairman of the Board's Nominating and Corporate Governance Committee. On September 25, 2025, the Company issued a press release announcing the appointment of Mr. Doherty as Chairman of the Board. A copy of the press release is furnished as Exhibit 99.1 hereto. Exhibit 99.1 shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release dated September 25, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. VICARIOUS SURGICAL INC. By: /s/ Stephen From Name: Stephen From Title: Chief Executive Officer Date: September 25, 2025 2